MUSL — Promino Nutritional Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- CA$10.50m
- CA$13.12m
- CA$0.48m
Annual cashflow statement for Promino Nutritional Sciences, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.5 | -7.72 | -8.78 | -10.3 | -5.81 |
| Depreciation | |||||
| Non-Cash Items | 0 | 4.41 | 1.57 | 1.63 | 1.41 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.261 | 1 | -2.81 | 4.19 | 2.58 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.6 | -2.16 | -9.94 | -4.5 | -1.79 |
| Capital Expenditures | -0.024 | -0.01 | -0.037 | -0.023 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 1.86 | 0 | 0.003 | 0.001 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.024 | 1.85 | -0.037 | -0.02 | 0.001 |
| Financing Cash Flow Items | -0.133 | 0 | -1.17 | -0.415 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.62 | 0.221 | 10.5 | 4.29 | 1.72 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.007 | -0.017 | 0.405 | -0.489 | -0.003 |